Skip to content

A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women

Cluster Randomized Trial of a Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03880461
Enrollment
1335
Registered
2019-03-19
Start date
2021-01-21
Completion date
2025-03-31
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Weight Gain

Keywords

Gestational weight gain, Lifestyle, Intervention, Body weight, Overweight, Obesity, Signs and Symptoms, Body weight changes

Brief summary

The aim of this trial is to investigate the effectiveness of a mobile health (mhealth) intervention to help overweight and obese women achieve appropriate gestational weight gain (GWG) for their pre-pregnancy body mass index (BMI). The goal of the intervention is to help women achieve GWG within the range recommended by the Institute of Medicine. The investigators propose an adaptive intervention that begins with an effective, yet low resource-intensive treatment and then provides incremental support and resources only to patients who need them. The intervention includes: 1) an mHealth tool allowing data to be automatically transmitted to a mobile website; 2) personalized text messages; and 3) personalized 1:1 telephone coaching sessions. The latter more intensive components are reserved for patients whose GWG is not within the IOM guidelines. The lifestyle intervention will be delivered through 1 telephone counseling session with a study dietician trained in motivational interviewing techniques, as well as through technology-based tools, automated text messages and weekly e-mails of core lifestyle intervention sessions. Personalized text messages and 1:1 telephone coaching sessions will be given to those who are not meeting the GWG guidelines. The lifestyle intervention will be compared to usual medical care. Maternal outcomes will be assessed shortly before delivery and at 6 weeks postpartum. Infant birthweight and weight at one year will also be assessed.

Interventions

BEHAVIORALLifestyle Intervention

Behavioral lifestyle intervention

Sponsors

Kaiser Permanente
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant * Women receiving prenatal care at Kaiser Permanente San Francisco and Oakland and whose obstetric care clinicians consent to participate; * Pregravid BMI 25 to \<40 (as determined from a measured pregravid weight in electronic medical record); * Has access to a smartphone and Wi-Fi; * Provides informed consent to participate.

Exclusion criteria

* Multiple births; * Planning to move out of the area during the study period; * Inability to speak, read, or understand English; * Placed on bed rest at time of enrollment; -\>15 weeks' gestation at enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Total Gestational Weight Gain (GWG)From 10 gestational weeks until time of delivery (duration of up to 9 months)Calculated as last measured pregnancy weight at the time of delivery minus measured weight at 10 gestational weeks
Rate of Total GWGFrom 10 gestational weeks until time of delivery (duration of up to 9 months)Calculated as total gestational weight gain / (# of weeks between 10 gestational weeks and the time of delivery)
Proportion of Women Meeting the Institute of Medicine's GWG RecommendationFrom 10 gestational weeks until time of delivery (duration of up to 9 months)Proportion of women meeting the IOM's GWG recommendation for weekly rate of GWG

Secondary

MeasureTime frameDescription
Trimester-specific Weekly Rate of GWG0 - 13 gestational weeks; 14 - 26 gestational weeks; 27 - 40 gestational weeks
GWG Trajectory Throughout PregnancyFrom 10 gestational weeks until time of delivery (duration of up to 9 months)
Change in Moderate to Vigorous Physical Activity (in MET Hrs/Week) as Assessed by the Pregnancy Physical Activity Questionnaire (PPAQ)Between 12 weeks and 33 weeks of pregnancyWe will assess change in moderate to vigorous physical activity between study assessments in pregnancy. The sports and exercise domain encompasses 10 PPAQ activities of moderate intensity (ranging 3.2 MET to 6 MET) and 2 PPAQ activities of vigorous intensity (6.5 MET and 7 MET). The volumes of all activities in the sports and exercise domain will be summed to arrive at an estimate of overall volume of moderate to vigorous intensity sports and exercise activity, expressed in MET hours per week. Higher levels of activity are generally associated with better outcomes. The distributions of all physical activity variables will be assessed for outliers.
Overall Diet Quality According to the Healthy Eating Index-2015 (HEI-2015)Assessed at 12 weeks of pregnancyThe HEI-2015 reflects adherence to the 2015-2020 Dietary Guidelines for Americans; it is comprised of 13 components as well as an overall score. The scoring system ranges from 0 to 100, where higher values indicate a better diet quality.
Postpartum Weight RetentionAssessed at 6 weeks postpartum
The Proportion of Infants With Appropriate Birthweight (>10th and <90th Percentile of Sex-, Gestational Age-, and Racial/Ethnic-specific Distribution)Assessed at birth
Infant Growth (BMI Z-score)From birth to 12 months of age

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention Arm - PATIENTS
In addition to usual medical care, patients in the intervention arm will receive access to mHealth tools to manage gestational weight gain (GWG), including a scale, physical activity tracker, and smartphone application, and for those not meeting GWG guidelines, personalized text messages and personalized 1-1 coaching sessions.
714
Usual Care Arm - PATIENTS
Patients in the usual care arm will receive the standard obstetric care offered at Kaiser Permanente Northern California.
621
Total1,335

Baseline characteristics

CharacteristicIntervention Arm - PATIENTSUsual Care Arm - PATIENTSTotal
Age, Continuous33.3 years
STANDARD_DEVIATION 4.7
33.4 years
STANDARD_DEVIATION 4.5
33.4 years
STANDARD_DEVIATION 4.6
Age, Customized
Age (years)
21 - 29
158 Participants122 Participants280 Participants
Age, Customized
Age (years)
30 - 34
259 Participants238 Participants497 Participants
Age, Customized
Age (years)
35 - 39
234 Participants215 Participants449 Participants
Age, Customized
Age (years)
40 - 46
63 Participants46 Participants109 Participants
Parity (Customized)
Multiparous
103 Participants127 Participants230 Participants
Parity (Customized)
Nulliparous
319 Participants238 Participants557 Participants
Parity (Customized)
Primiparous
270 Participants239 Participants509 Participants
Parity (Customized)
Unknown / Missing
22 Participants17 Participants39 Participants
Pre-pregnancy BMI (Continuous)29.7 kg/m2
STANDARD_DEVIATION 3.8
30.0 kg/m2
STANDARD_DEVIATION 3.9
29.8 kg/m2
STANDARD_DEVIATION 3.8
Pre-pregnancy BMI (Customized)
Obese (30.0 - 39.9)
284 Participants267 Participants551 Participants
Pre-pregnancy BMI (Customized)
Overweight (25.0 - 29.9)
430 Participants354 Participants784 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Asian / Pacific Islander
175 Participants137 Participants312 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Black
41 Participants40 Participants81 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Hispanic
186 Participants165 Participants351 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Islander
6 Participants4 Participants10 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Multiracial
37 Participants41 Participants78 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Native American
10 Participants4 Participants14 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Non-Hispanic White
237 Participants211 Participants448 Participants
Race/Ethnicity, Customized
Race / Ethnicity
Unknown / Missing
22 Participants19 Participants41 Participants
Region of Enrollment
United States
714 participants621 participants1335 participants
Sex: Female, Male
Female
714 Participants621 Participants1335 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 7140 / 621
other
Total, other adverse events
44 / 71429 / 621
serious
Total, serious adverse events
0 / 7140 / 621

Outcome results

Primary

Proportion of Women Meeting the Institute of Medicine's GWG Recommendation

Proportion of women meeting the IOM's GWG recommendation for weekly rate of GWG

Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Intervention Arm - PATIENTSProportion of Women Meeting the Institute of Medicine's GWG Recommendation172 Participants
Usual Care Arm - PATIENTSProportion of Women Meeting the Institute of Medicine's GWG Recommendation126 Participants
p-value: 0.108ANOVA
Primary

Rate of Total GWG

Calculated as total gestational weight gain / (# of weeks between 10 gestational weeks and the time of delivery)

Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

ArmMeasureValue (MEAN)Dispersion
Intervention Arm - PATIENTSRate of Total GWG0.26 kilograms/weekStandard Deviation 0.17
Usual Care Arm - PATIENTSRate of Total GWG0.28 kilograms/weekStandard Deviation 0.16
p-value: 0.003t-test, 2 sided
Primary

Total Gestational Weight Gain (GWG)

Calculated as last measured pregnancy weight at the time of delivery minus measured weight at 10 gestational weeks

Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

ArmMeasureValue (MEAN)Dispersion
Intervention Arm - PATIENTSTotal Gestational Weight Gain (GWG)10.5 kilogramsStandard Deviation 5.7
Usual Care Arm - PATIENTSTotal Gestational Weight Gain (GWG)11.3 kilogramsStandard Deviation 5.9
p-value: 0.014t-test, 2 sided
Secondary

Change in Moderate to Vigorous Physical Activity (in MET Hrs/Week) as Assessed by the Pregnancy Physical Activity Questionnaire (PPAQ)

We will assess change in moderate to vigorous physical activity between study assessments in pregnancy. The sports and exercise domain encompasses 10 PPAQ activities of moderate intensity (ranging 3.2 MET to 6 MET) and 2 PPAQ activities of vigorous intensity (6.5 MET and 7 MET). The volumes of all activities in the sports and exercise domain will be summed to arrive at an estimate of overall volume of moderate to vigorous intensity sports and exercise activity, expressed in MET hours per week. Higher levels of activity are generally associated with better outcomes. The distributions of all physical activity variables will be assessed for outliers.

Time frame: Between 12 weeks and 33 weeks of pregnancy

Secondary

GWG Trajectory Throughout Pregnancy

Time frame: From 10 gestational weeks until time of delivery (duration of up to 9 months)

Secondary

Infant Growth (BMI Z-score)

Time frame: From birth to 12 months of age

Secondary

Overall Diet Quality According to the Healthy Eating Index-2015 (HEI-2015)

The HEI-2015 reflects adherence to the 2015-2020 Dietary Guidelines for Americans; it is comprised of 13 components as well as an overall score. The scoring system ranges from 0 to 100, where higher values indicate a better diet quality.

Time frame: Assessed at 12 weeks of pregnancy

Secondary

Postpartum Weight Retention

Time frame: Assessed at 6 weeks postpartum

Secondary

The Proportion of Infants With Appropriate Birthweight (>10th and <90th Percentile of Sex-, Gestational Age-, and Racial/Ethnic-specific Distribution)

Time frame: Assessed at birth

Secondary

Trimester-specific Weekly Rate of GWG

Time frame: 0 - 13 gestational weeks; 14 - 26 gestational weeks; 27 - 40 gestational weeks

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026